A Study of IMC-TR1 in Participants With Advanced Solid Tumors

Clinical trial NCT01646203 · COMPLETED

Trial details

NCT number: NCT01646203
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms Tumor

Start date: 2012-07-01
Primary completion: 2014-10-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.